Based on our previous observation that SOX17 overexpression could sensitize ESCC cells to radiation treatment [24], we further investigated whether ZVI@CMC combined with radiation treatment could augment anti-tumor efficacy and overcome resistance in NRF2high ESCC cells. The gene discussed is SOX17; the disease is neoplasm.